E.coli O157 polysaccharide protein conjugate vaccine (Lanzhou institute of biological products)

大肠杆菌O157多糖蛋白结合疫苗（兰州生物制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameE.coli O157 polysaccharide protein conjugate vaccine (Lanzhou institute of biological products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEscherichia coli Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesLanzhou Institute Of Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsEscherichia coli Infections

Other Information

ATC CodeN/A